Evropská unie - dánština - EMA (European Medicines Agency)

sanofi winthrop industrie - clopidogrelhydrogensulfat - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - antitrombotiske midler - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event. forebyggelse af atherothrombotic og tromboemboliske hændelser i atrial fibrillationin voksne patienter med atrieflimren, der har mindst en risikofaktor for vaskulære hændelser, er ikke egnede til behandling med vitamin-k-antagonister, og som har en lav risiko for blødning, clopidogrel er indiceret i kombination med asa til forebyggelse af atherothrombotic og tromboemboliske hændelser, herunder slagtilfælde.

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - acetylsalicylsyre, dipyridamol - depotkapsler, hårde - 200+25 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - acetylsalicylsyre, dipyridamol - depotkapsler, hårde - 200 + 25 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - acetylsalicylsyre, codeinphosphathemihydrat - brusetabletter - 500+10 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - acetylsalicylsyre, codeinphosphathemihydrat, magnesiumhydroxid, tungt - filmovertrukne tabletter - 500+9,6 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - acetylsalicylsyre, dipyridamol - depotkapsler, hårde - 200 + 25 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - acetylsalicylsyre, dipyridamol - kapsler med modificeret udløsning, hårde - 200+25 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

orion corporation - acetylsalicylsyre, dipyridamol - kapsler med modificeret udløsning, hårde - 200+25 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris aps - acetylsalicylsyre, caffein - brusetabletter - 500+50 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris aps - acetylsalicylsyre, caffein - brusetabletter - 500+50 mg